Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis

Chen, D; Wu, YS; Lin, HP; Wang, YH; Li, LH; Zhang, T

Li, LH; Zhang, T (reprint author), Chongqing Med Univ, Dept Oncol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing, Peoples R China.

CANCER MANAGEMENT AND RESEARCH, 2018; 10 (): 2915

Abstract

Background: TAS-102 has been applied to metastatic colorectal cancer (mCRC) patients who had received at least two prior regimens of standard chemothe......

Full Text Link